Floatz logo

IMMUNOGLOBULIN, ANTI-(HUMAN CD3 ANTIGEN/CD19 ANTIGEN) (MOUSE CLONE PDISC3X19-LL FV FRAGMENT DIMER PRECURSOR) FUSION PROTEIN WITH GENE C-MYC PROTEIN EPITOPE FUSION PROTEIN WITH HEXAHISTIDINE PEPTIDE

Leukemia, B-Cell

Affimed GmbHmonoclonal_antibodyPhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
89/ 100

Competitive context

13 Active assets in the Leukemia, B-Cell cohort.

Asset / SponsorPhaseRating
Fludarabine
Dartmouth-Hitchcock Medical Center
Phase 4BBB
Ibrutinib
Loxo Oncology, Inc.
Phase 4BBB
Busulphan
Dartmouth-Hitchcock Medical Center
Phase 4BB
Pirtobrutinib
Loxo Oncology, Inc.
Phase 3BB
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
University of Washington
Phase 2BB

View all 50 →

Same molecule, other indications

IMMUNOGLOBULIN, ANTI-(HUMAN CD3 ANTIGEN/CD19 ANTIGEN) (MOUSE CLONE PDISC3X19-LL FV FRAGMENT DIMER PRECURSOR) FUSION PROTEIN WITH GENE C-MYC PROTEIN EPITOPE FUSION PROTEIN WITH HEXAHISTIDINE PEPTIDE is also rated in:

B-cell non-Hodgkin lymphomaDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →